Completed OBSERVATIONAL NCT01304511

Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®

Post-Marketing Surveillance Orgalutran (Ganirelix)®

Sponsor: Organon and Co

Interventions Orgalutran

Updated 9 times since 2017 Last updated: Apr 1, 2024 Started: Feb 28, 2005 Primary completion: Dec 31, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Fertilization in Vitro and is currently completed. Organon and Co leads this study, which shows 9 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2024 — Jul 2024 [monthly]

Completed
Mar 2022 — May 2024 [monthly]

Completed
Jan 2021 — Mar 2022 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Organon and Co

Data source: Organon and Co

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.